POSTER: CT-321 Safety and Efficacy of an Academic Anti-CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy for Non-Hodgkin Lymphoma and Acute Lymphoblastic Leukemia Developed in Brazil: Increasing Access in a Public Health System
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA(2023)
关键词
Cellular therapy,CAR-T cell,accessibility,public health system
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要